Sequenom (SQNM) Pressures into JPMorgan Presentation

Go back to Sequenom (SQNM) Pressures into JPMorgan Presentation

Sequenom (SQNM) Prelim FY12 Revs Come in Ahead of Views

January 7, 2013 6:26 AM EST

Sequenom, Inc. (NASDAQ: SQNM) announced preliminary highlights of the Company's 2012 performance and accomplishments.

Initial 2012 Performance Results (unaudited)

* Total revenue of approximately $89 million, growth of approximately 59 percent year-over-year for 2012. The Street was looking for revs of $85.3 million.
* Diagnostic services revenues of approximately $46 million,... More